Literature DB >> 8892938

Foot-and-mouth disease virus 2A protease mediates cleavage in attenuated Sabin 3 poliovirus vectors engineered for delivery of foreign antigens.

N M Mattion1, E C Harnish, J C Crowley, P A Reilly.   

Abstract

Poliovirus vectors are being studied as potential vaccine delivery systems, with foreign genetic sequences incorporated as part of the viral genome. The foreign sequences are expressed as part of the viral polyprotein. Addition of proteolytic cleavage sites at the junction of the foreign polypeptide and the viral proteins results in cleavage during polyprotein processing. The ability of foot-and-mouth disease virus (FMDV) 2A to mediate proteolytic cleavage in the context of poliovirus vectors was studied. The results demonstrate that FMDV 2A is able to generate cleavage of the foreign antigen from the viral polyprotein. A second cleavage event between the FMDV 2A peptide and the foreign protein was also observed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892938      PMCID: PMC190887     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating.

Authors:  J M Tatem; C Weeks-Levy; A Georgiu; S J DiMichele; E J Gorgacz; V R Racaniello; F R Cano; S J Mento
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 2.  Oral immunization and secretory immunity to viruses.

Authors:  P L Ogra; E E Leibovitz; G Zhao-Ri
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

3.  Cleavage of synthetic peptides by purified poliovirus 3C proteinase.

Authors:  P V Pallai; F Burkhardt; M Skoog; K Schreiner; P Bax; K A Cohen; G Hansen; D E Palladino; K S Harris; M J Nicklin
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

4.  Myristylation of picornavirus capsid protein VP4 and its structural significance.

Authors:  M Chow; J F Newman; D Filman; J M Hogle; D J Rowlands; F Brown
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

5.  Structural domains of the poliovirus polyprotein are major determinants for proteolytic cleavage at Gln-Gly pairs.

Authors:  M F Ypma-Wong; D J Filman; J M Hogle; B L Semler
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

6.  Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.

Authors:  S van der Werf; J Bradley; E Wimmer; F W Studier; J J Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

7.  Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.

Authors:  V J Isola; R J Eisenberg; G R Siebert; C J Heilman; W C Wilcox; G H Cohen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

8.  Advantages and disadvantages of killed and live poliomyelitis vaccines.

Authors:  J L Melnick
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

9.  Poliovirus protease 3C mediates cleavage of microtubule-associated protein 4.

Authors:  M Joachims; K S Harris; D Etchison
Journal:  Virology       Date:  1995-08-20       Impact factor: 3.616

10.  Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence.

Authors:  M D Ryan; A M King; G P Thomas
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

View more
  10 in total

1.  Complete eradication of xenograft hepatoma by oncolytic adenovirus ZD55 harboring TRAIL-IETD-Smac gene with broad antitumor effect.

Authors:  Shi-Bing Wang; Yuan Tan; Wen Lei; Yi-Gang Wang; Xiu-Mei Zhou; Xiao-Yuan Jia; Kang-Jian Zhang; Liang Chu; Xin-Yuan Liu; Wen-Bin Qian
Journal:  Hum Gene Ther       Date:  2012-07-20       Impact factor: 5.695

2.  RNA silencing mediated by direct repeats in maize: a potential tool for functional genomics.

Authors:  Xiuping Xu; Dengyun Zhu; Qian Zhao; Guangming Ao; Chonglie Ma; Jingjuan Yu
Journal:  Mol Biotechnol       Date:  2008-11-22       Impact factor: 2.695

3.  Sindbis-group alphavirus replication in periosteum and endosteum of long bones in adult mice.

Authors:  M T Heise; D A Simpson; R E Johnston
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Sindbis virus vectors designed to express a foreign protein as a cleavable component of the viral structural polyprotein.

Authors:  John M Thomas; William B Klimstra; Kate D Ryman; Hans W Heidner
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Characterization of replication-competent hepatitis A virus constructs containing insertions at the N terminus of the polyprotein.

Authors:  Y Zhang; G G Kaplan
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Two-helper RNA system for production of recombinant Semliki forest virus particles.

Authors:  C Smerdou; P Liljeström
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  Characterisation and partial sequence analysis of two novel cypoviruses isolated from the winter moth Operophtera brumata (Lepidoptera: Geometridae).

Authors:  Robert I Graham; Shujing Rao; Steven M Sait; Peter P C Mertens; Rosemary S Hails; Robert D Possee
Journal:  Virus Genes       Date:  2007-06-02       Impact factor: 2.332

8.  Development of expression vectors based on pepino mosaic virus.

Authors:  Raquel N Sempere; Pedro Gómez; Verónica Truniger; Miguel A Aranda
Journal:  Plant Methods       Date:  2011-03-11       Impact factor: 4.993

9.  Identification and characterization of vp7 gene in Bombyx mori cytoplasmic polyhedrosis virus.

Authors:  Lei He; Xiaolong Hu; Min Zhu; Zi Liang; Fei Chen; Liyuan Zhu; Sulan Kuang; Guangli Cao; Renyu Xue; Chengliang Gong
Journal:  Gene       Date:  2017-06-28       Impact factor: 3.688

10.  Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response.

Authors:  Michael K Lo; Mark E Peeples; William J Bellini; Stuart T Nichol; Paul A Rota; Christina F Spiropoulou
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.